Effect of long-term serum sodium levels on the prognosis of patients on maintenance hemodialysis

被引:1
|
作者
Chen, Siyu [1 ,2 ,3 ,4 ,5 ]
Pan, Bin [1 ,2 ,3 ,4 ,5 ]
Lou, Xiaowei [1 ,2 ,3 ,4 ,5 ]
Chen, Jianghua [1 ,2 ,3 ,4 ,5 ]
Zhang, Ping [1 ,2 ,3 ,4 ,5 ,6 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Kidney Dis Ctr, Hangzhou, Zhejiang Provin, Peoples R China
[2] Key Lab Kidney Dis Prevent & Control Technol, Hangzhou, Zhejiang Provin, Peoples R China
[3] Natl Key Clin Dept Kidney Dis, Hangzhou, Zhejiang Provin, Peoples R China
[4] Zhejiang Univ, Inst Nephrol, Hangzhou, Zhejiang Provin, Peoples R China
[5] Zhejiang Clin Res Ctr Kidney & Urinary Syst Dis, Hangzhou, Zhejiang Provin, Peoples R China
[6] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Kidney Dis Ctr, Qingchun Rd 79, Hangzhou 310003, Zhejiang Provin, Peoples R China
关键词
Low sodium; high sodium; hemodialysis; risk factors; prognosis; INTERDIALYTIC WEIGHT-GAIN; DIALYSATE SODIUM; KIDNEY-DISEASE; RISK-FACTORS; MORTALITY; HYPONATREMIA; HYPERNATREMIA; PREVALENCE; DYSNATREMIAS; ASSOCIATION;
D O I
10.1080/0886022X.2024.2314629
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Abnormal serum Na (SNa) levels are common in patients with chronic kidney disease (CKD) which is associated with increased morbidity and mortality. There are relatively few studies on the effect of SNa indicators on the prognosis of patients undergoing maintenance hemodialysis (MHD). We aim to investigate the effect of long-term SNa levels on the survival and prognosis of patients undergoing hemodialysis (HD). Newly entered HD patients in the registration system of Zhejiang Provincial Dialysis Quality Control Center between January 1, 2010 and December 31, 2019 were included and followed up until December 31, 2020. Multiple sodium levels were collected from patients, defining long-term SNa as the mean of multiple SNa, according to which patients were grouped, with the prognostic differences between subgroups compared by Kaplan-Meier modeling and multifactorial Cox regression modeling. Finally, a total of 21,701 patients were included in this study and Cox regression showed that decreased SNa levels (Na < 135 mmol/L, HR = 1.704, 95% CI 1.408-2.063, p < 0.001; 135 <= Na <= 137.5 mmol/L, HR = 1.127,95% CI 1.016-1.250, p = 0.024) and elevated SNa levels (142.5 < Na <= 145mmol/L, HR = 1.198, 95% CI 1.063-1.350, p = 0.003; Na > 145mmol/L, HR = 2.150, 95% CI 1.615-2.863, p < 0.001) were all independent risk factors for all-cause mortality in MHD patients.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] ESTIMATION OF LONG-TERM CARE NEEDS IN PATIENTS UNDER MAINTENANCE HEMODIALYSIS
    Hung, M. C.
    Wang, J. D.
    VALUE IN HEALTH, 2013, 16 (03) : A14 - A14
  • [32] PLASMA ERYTHROPOIETIN LEVELS IN PATIENTS UNDERGOING LONG-TERM HEMODIALYSIS
    RAICH, PC
    KORST, DR
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1978, 102 (02) : 73 - 75
  • [33] PLASMA FLAVIN LEVELS OF PATIENTS RECEIVING LONG-TERM HEMODIALYSIS
    ITO, T
    YAGI, K
    OHISHI, N
    NIWA, T
    MATSUI, E
    CLINICA CHIMICA ACTA, 1972, 39 (01) : 125 - +
  • [34] The effect of serum uric acid levels on the long-term prognosis of patients with non-ST-elevation myocardial infarction
    Kuzma, Lukasz
    Kulikowska, Agata
    Kurasz, Anna
    Niwinska, Marta Maria
    Zalewska-Adamiec, Malgorzata
    Dobrzycki, Slawomir
    Bachorzewska-Gajewska, Hanna
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 29 (11): : 1255 - 1263
  • [35] Long-term effect of paricalcitol in hemodialysis patients.
    Pai, AB
    Lin, S
    Arruda, J
    Lau, AH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P92 - P92
  • [36] Long-term effects of sodium valproate in amylasis levels in the blood serum
    Patiakas, S.
    Panagiotellis, K.
    Palaiologou, M.
    Charalampous, C.
    Tsiatsiou, U.
    VIRCHOWS ARCHIV, 2011, 459 : S272 - S272
  • [37] Does atorvastatin influence serum C-reactive protein levels in patients on long-term hemodialysis?
    Vernaglione, L
    Cristofano, C
    Muscogiuri, P
    Chimienti, S
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (03) : 471 - 478
  • [38] Efficacy for Anemia and Changes in Serum Ferritin Levels by Long-Term Oral Iron Administration in Hemodialysis Patients
    Daimon, Shoichiro
    THERAPEUTIC APHERESIS AND DIALYSIS, 2019, 23 (05) : 444 - 450
  • [39] Serum prolactin level in patients undergoing long-term hemodialysis.
    Kim, JH
    Oh, SM
    Lee, KH
    Song, JS
    Cheon, KT
    Park, SK
    Kang, SK
    KIDNEY INTERNATIONAL, 1996, 50 (02) : 694 - 694
  • [40] Serum paraoxonase activities in endemic nephropathy patients on long-term hemodialysis
    Tadijanovic, M.
    Rekic, B.
    Simeon-Rudolf, V
    Baricic, M.
    Juretic, D.
    Miskic, B.
    COLLEGIUM ANTROPOLOGICUM, 2006, 30 : 57 - 57